Since Src over-expression has been correlated with highly aggressive stages of prostate cancer [37], we sought to determine if Src family kinases (SFKs), cSrc in particular is responsible for Y216 phosphorylation of GSK-3 and its subsequent activation. Here, SRC is linked to prostate carcinoma.